HeartBeam PE Ratio 2020-2024 | BEAT
Current and historical p/e ratio for HeartBeam (BEAT) from 2020 to 2024. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. HeartBeam PE ratio as of May 14, 2024 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| HeartBeam PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-05-15 | 2.15 | 0.00 | |
| 2024-03-31 | 2.18 | $-0.59 | 0.00 |
| 2023-12-31 | 2.35 | $-0.92 | 0.00 |
| 2023-09-30 | 2.15 | $-1.24 | 0.00 |
| 2023-06-30 | 2.41 | $-1.55 | 0.00 |
| 2023-03-31 | 2.27 | $-1.82 | 0.00 |
| 2022-12-31 | 4.88 | $-1.59 | 0.00 |
| 2022-09-30 | 3.90 | $-1.54 | 0.00 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.054B | $0.000B |
| HeartBeam Inc. is a development stage digital healthcare company with proprietary ECG telemedicine technology. HeartBeam Inc. is based in SANTA CLARA, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.755B | 20.18 |
| Inspire Medical Systems (INSP) | United States | $4.712B | 0.00 |
| Axonics (AXNX) | United States | $3.441B | 0.00 |
| 10x Genomics (TXG) | United States | $3.165B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $3.092B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $2.951B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.949B | 0.00 |
| Enovis (ENOV) | United States | $2.880B | 21.34 |
| Azenta (AZTA) | United States | $2.763B | 155.30 |
| Privia Health (PRVA) | United States | $2.154B | 120.33 |
| Schrodinger (SDGR) | United States | $1.690B | 0.00 |
| Omnicell (OMCL) | United States | $1.391B | 48.06 |
| Phreesia (PHR) | United States | $1.251B | 0.00 |
| Standard BioTools (LAB) | United States | $0.737B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.668B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.643B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.505B | 0.00 |
| Talkspace (TALK) | United States | $0.484B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.404B | 0.00 |
| Pulmonx (LUNG) | United States | $0.346B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.303B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.212B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.207B | 0.00 |
| Outset Medical (OM) | United States | $0.181B | 0.00 |
| American Well (AMWL) | United States | $0.148B | 0.00 |
| TruBridge (TBRG) | United States | $0.132B | 7.10 |
| MSP Recovery (LIFW) | United States | $0.113B | 0.00 |
| 111 (YI) | China | $0.110B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.073B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.068B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.063B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | China | $0.053B | 0.00 |
| Movano (MOVE) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.035B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.032B | 0.00 |
| CareCloud (CCLD) | United States | $0.030B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Cue Health (HLTH) | United States | $0.021B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.020B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.013B | 0.00 |
| Syra Health (SYRA) | United States | $0.011B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Transgenomic (PRPO) | United States | $0.010B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.007B | 0.00 |
| HeartSciences (HSCS) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.001B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |